Can I Take Mounjaro Alongside Levothyroxine?

Does Mounjaro actually interfere with how levothyroxine works?

Mounjaro is a dual GIP and GLP-1 receptor agonist. One of its known effects is slowing the rate at which food and other contents leave your stomach, a mechanism called delayed gastric emptying. This is relevant for levothyroxine because that medicine relies on being absorbed rapidly, on an empty stomach, before anything else passes through. The concern is not that Mounjaro blocks levothyroxine chemically; it is that the slower gastric environment might blunt or delay absorption, particularly if the two medicines are taken at overlapping times.

In practice, most people who take levothyroxine already follow a strict morning routine: tablet first, on an empty stomach, then wait at least 30 minutes before any food or other medicines. That routine creates a reasonable buffer. If you take your levothyroxine first thing and inject Mounjaro later in the week (it is a once-weekly injection), the direct overlap is generally small. Still, the NHS patient information for tirzepatide notes that slower gastric emptying is a known effect, and it is the kind of detail a prescriber weighs up individually rather than applying a blanket rule. If you are unsure whether your routine creates enough separation, that is exactly the question to raise at consultation.

It is also worth noting that Mounjaro carries a Black Triangle (▼) designation from the MHRA, meaning it is subject to additional monitoring, another reason thorough clinical assessment matters before and during treatment.

Why might your levothyroxine dose need reviewing once you start losing weight?

Levothyroxine is dosed partly on body weight. As a general principle, a higher body weight tends to require a higher dose to maintain the same circulating thyroid hormone levels. The reverse is also true: meaningful weight loss can mean your existing dose becomes slightly more than your body now needs.

In clinical trials, tirzepatide produced average weight reductions of around 20–21% at the highest dose over 72 weeks, as reported in SURMOUNT-1, published in the New England Journal of Medicine. That scale of change is significant enough that thyroid hormone levels can drift outside their previous range, even if your underlying thyroid condition is stable. This is not unique to Mounjaro (any treatment that produces substantial weight loss carries the same implication) but it is a reason to keep your GP and the prescribing team informed throughout treatment.

Regular thyroid function tests (TFTs) are standard care for anyone on levothyroxine, but the frequency may need to increase in the months after starting a weight-management medicine. Your GP is well placed to coordinate this. If you have an underactive thyroid managed with levothyroxine, that context is worth reading alongside this page.

Is there anything in the clinical guidance that flags this combination specifically?

The Mounjaro Summary of Product Characteristics (SmPC) does not list levothyroxine as a contraindicated medicine, and neither does the BNF entry for tirzepatide. What the SmPC does note, under interactions, is that medicines with narrow therapeutic indices (those where even small absorption changes can matter) warrant attention. Levothyroxine sits in that category. The guidance does not say the combination is unsafe; it says it warrants prescriber awareness and, where relevant, monitoring.

If you are researching whether weight-loss treatment is appropriate alongside other thyroid conditions, the picture for hyperthyroidism and Mounjaro is a different clinical question and covered separately. For a broader look at how thyroid health interacts with eligibility, the underactive thyroid and Mounjaro page covers the condition-level context in more depth.

Understanding the general eligibility criteria for Mounjaro is a useful starting point too, particularly if you are still working out whether you qualify for private treatment. BMI thresholds and qualifying conditions are explained on the BMI for Mounjaro page.

What should you do before starting Mounjaro if you take levothyroxine?

The answer is straightforward: tell the prescriber. This is not a reason to expect a refusal, but it is information that shapes how your care is set up, including whether your GP should increase the frequency of TFTs and whether your levothyroxine-taking routine needs any adjustment.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally the same day it is submitted. That includes your full medication list. If you mention levothyroxine, it is factored into the clinical decision, not passed over by a questionnaire. A question our prescribers hear regularly is whether thyroid medication disqualifies someone from treatment, in most cases it does not, but the answer depends on the full picture, not a single medicine name.

One practical point: if you tend to order your levothyroxine on a Monday morning before the school run, note that the 12pm cut-off for same-day dispatch applies to Mounjaro orders too, once your prescription is approved. You can read about how Mounjaro works in full, or check the weight-loss treatment overview for broader context on what private treatment involves. If you have questions about cost, the Mounjaro cost page sets out what is included in a private prescription. When you are ready, starting a free consultation is the next step.